TrialAmerican journal of respiratory and critical care medicine2022

Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial.

Veronique De Jager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.